Syndromes predisposing to leukemia are a major cause of inherited cytopenias in children.


Journal

Haematologica
ISSN: 1592-8721
Titre abrégé: Haematologica
Pays: Italy
ID NLM: 0417435

Informations de publication

Date de publication:
01 09 2022
Historique:
received: 30 09 2021
pubmed: 18 3 2022
medline: 9 9 2022
entrez: 17 3 2022
Statut: epublish

Résumé

Prolonged cytopenias are a non-specific sign with a wide differential diagnosis. Among inherited disorders, cytopenias predisposing to leukemia require a timely and accurate diagnosis to ensure appropriate medical management, including adequate monitoring and stem cell transplantation prior to the development of leukemia. We aimed to define the types and prevalences of the genetic causes leading to persistent cytopenias in children. The study comprises children with persistent cytopenias, myelodysplastic syndrome, aplastic anemia, or suspected inherited bone marrow failure syndromes, who were referred for genetic evaluation from all pediatric hematology centers in Israel during 2016-2019. For variant detection, we used Sanger sequencing of commonly mutated genes and a custom-made targeted next-generation sequencing panel covering 226 genes known to be mutated in inherited cytopenias; the minority subsequently underwent whole exome sequencing. In total, 189 children with persistent cytopenias underwent a genetic evaluation. Pathogenic and likely pathogenic variants were identified in 59 patients (31.2%), including 47 with leukemia predisposing syndromes. Most of the latter (32, 68.1%) had inherited bone marrow failure syndromes, nine (19.1%) had inherited thrombocytopenia predisposing to leukemia, and three each (6.4%) had predisposition to myelodysplastic syndrome or congenital neutropenia. Twelve patients had cytopenias with no known leukemia predisposition, including nine children with inherited thrombocytopenia and three with congenital neutropenia. In summary, almost one third of 189 children referred with persistent cytopenias had an underlying inherited disorder; 79.7% of whom had a germline predisposition to leukemia. Precise diagnosis of children with cytopenias should direct follow-up and management programs and may positively impact disease outcome.

Identifiants

pubmed: 35295078
doi: 10.3324/haematol.2021.280116
pmc: PMC9425329
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2081-2095

Références

Leukemia. 2021 Aug;35(8):2439-2444
pubmed: 33510405
J Clin Invest. 2014 Feb;124(2):580-91
pubmed: 24430186
Curr Opin Oncol. 2018 Nov;30(6):402-408
pubmed: 30222640
Hum Mol Genet. 2019 Jan 1;28(1):133-142
pubmed: 30247636
Eur J Haematol. 2018 Sep;101(3):297-304
pubmed: 29786897
Genet Med. 2013 Sep;15(9):733-47
pubmed: 23887774
Hematology Am Soc Hematol Educ Program. 2016 Dec 2;2016(1):598-604
pubmed: 27913534
Blood Rev. 2018 Sep;32(5):361-367
pubmed: 29555368
Haematologica. 2016 Nov;101(11):1343-1350
pubmed: 27418648
High Throughput. 2018 Sep 14;7(3):
pubmed: 30223503
Blood. 2018 Sep 20;132(12):1318-1331
pubmed: 29914977
J Thromb Haemost. 2013 Jun;11(6):1006-19
pubmed: 23510089
Blood. 2011 Jun 16;117(24):6673-80
pubmed: 21467542
Pediatr Blood Cancer. 2018 Dec;65(12):e27361
pubmed: 30117263
Blood. 2020 Nov 26;136(22):2498-2506
pubmed: 33236764
Mol Genet Genomic Med. 2018 May;6(3):463-468
pubmed: 29633571
Hematology Am Soc Hematol Educ Program. 2017 Dec 8;2017(1):385-399
pubmed: 29222283
Haematologica. 2020 Feb 13;106(1):64-73
pubmed: 32054657
Front Pediatr. 2015 Jul 13;3:64
pubmed: 26217651
Nat Genet. 2014 Sep;46(9):1021-7
pubmed: 25129144
Hemasphere. 2021 Mar 09;5(4):e539
pubmed: 33718801
Blood Rev. 2010 May;24(3):101-22
pubmed: 20417588
Ann Intern Med. 2007 Apr 3;146(7):486-92
pubmed: 17404350
Pediatr Blood Cancer. 2020 Jun;67(6):e28237
pubmed: 32277798
Haematologica. 2015 Jan;100(1):42-8
pubmed: 25239263
Br J Haematol. 2017 May;177(4):526-542
pubmed: 28211564
Blood. 1976 Jul;48(1):63-70
pubmed: 779871
Am J Hum Genet. 2014 Feb 6;94(2):246-56
pubmed: 24507776
Gene. 2020 Oct 5;757:144938
pubmed: 32640305
Int J Lab Hematol. 2019 May;41 Suppl 1:131-141
pubmed: 31069978
Blood. 2013 May 9;121(19):3830-7, S1-7
pubmed: 23502222
Genet Med. 2015 May;17(5):405-24
pubmed: 25741868
Blood. 2019 Jun 20;133(25):2724-2728
pubmed: 30936069
Blood. 2016 May 19;127(20):2391-405
pubmed: 27069254
Blood. 2018 Feb 15;131(7):717-732
pubmed: 29146883
Am J Hematol. 2021 Sep 1;96(9):1077-1086
pubmed: 34000087
J Med Genet. 2015 Sep;52(9):575-84
pubmed: 26136524
Haematologica. 2018 Mar;103(3):427-437
pubmed: 29217778
Clin Cancer Res. 2017 Jun 1;23(11):e14-e22
pubmed: 28572263
Am J Hum Genet. 2011 Jan 7;88(1):115-20
pubmed: 21211618
Orphanet J Rare Dis. 2011 May 19;6:26
pubmed: 21595885
Br J Haematol. 2021 May;193(3):570-580
pubmed: 33368157
Thromb Res. 2012 Apr;129(4):534-5
pubmed: 22123584
J Hematol Oncol. 2017 Jan 18;10(1):18
pubmed: 28100250
Immunol Res. 2016 Aug;64(4):841-7
pubmed: 27216863
Nat Rev Dis Primers. 2017 Jun 08;3:17032
pubmed: 28593997
Semin Hematol. 2017 Apr;54(2):98-104
pubmed: 28637624
Nat Genet. 1999 Oct;23(2):166-75
pubmed: 10508512
Best Pract Res Clin Haematol. 2020 Sep;33(3):101197
pubmed: 33038986

Auteurs

Oded Gilad (O)

Department of Hematology-Oncology, Schneider Children's Medical Center of Israel, Petach Tikva, Israel; Sackler Faculty of Medicine, Aviv University, Aviv.

Orly Dgany (O)

Pediatric Hematology Laboratory, Felsenstein Medical Research Center, Petach Tikva.

Sharon Noy-Lotan (S)

Pediatric Hematology Laboratory, Felsenstein Medical Research Center, Petach Tikva.

Tanya Krasnov (T)

Pediatric Hematology Laboratory, Felsenstein Medical Research Center, Petach Tikva.

Joanne Yacobovich (J)

Department of Hematology-Oncology, Schneider Children's Medical Center of Israel, Petach Tikva, Israel; Sackler Faculty of Medicine, Aviv University, Aviv.

Ron Rabinowicz (R)

Department of Hematology-Oncology, Schneider Children's Medical Center of Israel, Petach Tikva, Israel; Sackler Faculty of Medicine, Aviv University, Aviv.

Tracie Goldberg (T)

Department of Hematology-Oncology, Schneider Children's Medical Center of Israel, Petach Tikva, Israel; Sackler Faculty of Medicine, Aviv University, Aviv.

Amir A Kuperman (AA)

Blood Coagulation Service and Pediatric Hematology Clinic, Galilee Medical Center, Nahariya, Israel; Azrieli Faculty of Medicine, Bar-Ilan University, Safed.

Abed Abu-Quider (A)

Pediatric Hematology, Soroka University Medical Center, Ben-Gurion University, Beer Sheva.

Hagit Miskin (H)

Pediatric Hematology Unit, Shaare Zedek Medical Center, Jerusalem, Israel; Faculty of Medicine, Hebrew University, Jerusalem.

Noa Kapelushnik (N)

Sackler Faculty of Medicine, Aviv University, Aviv, Israel; Goldschleger Eye Institute, Sheba Medical Center, Hashomer.

Noa Mandel-Shorer (N)

Department of Pediatric Hematology-Oncology, Ruth Rappaport Children's Hospital, Rambam Healthcare Campus; Rappaport Faculty of Medicine, Technion-Institute of Technology, Haifa.

Shai Shimony (S)

Sackler Faculty of Medicine, Aviv University, Aviv, Israel; Rabin Medical Center, Institute of Hematology, Davidoff Cancer Centre, Beilinson Hospital, Petach-Tikva, Israel; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.

Dan Harlev (D)

Pediatric Hematology-Oncology Department, Hadassah University Medical Center, Jerusalem.

Tal Ben-Ami (T)

Pediatric Hematology Unit, Kaplan Medical Center, Rehovot, Israel; Faculty of Medicine, Hebrew University of Jerusalem.

Etai Adam (E)

Pediatric Hematology-Oncology Department, Sheba Medical Center, Hashomer.

Carina Levin (C)

Rappaport Faculty of Medicine, Technion-Institute of Technology, Haifa, Israel; Pediatric Hematology Unit and Research Laboratory, Emek Medical Center, Afula.

Shraga Aviner (S)

Department of Pediatrics, Barzilai University Medical Center, Ashkelon, affiliated to Ben Gurion University, Beer-Sheva.

Ronit Elhasid (R)

Sackler Faculty of Medicine, Aviv University, Aviv, Israel; Department of Pediatric Hemato-Oncology, Aviv Medical Center.

Sivan Berger-Achituv (S)

Sackler Faculty of Medicine, Aviv University, Aviv, Israel; Department of Pediatric Hemato-Oncology, Aviv Medical Center.

Lilach Chaitman-Yerushalmi (L)

Genoox, Health Care Technology, Aviv.

Yona Kodman (Y)

Department of Hematology-Oncology, Schneider Children's Medical Center of Israel, Petach Tikva.

Nino Oniashvilli (N)

Department of Hematology-Oncology, Schneider Children's Medical Center of Israel, Petach Tikva.

Michal Hameiri-Grosman (M)

Department of Hematology-Oncology, Schneider Children's Medical Center of Israel, Petach Tikva.

Shai Izraeli (S)

Department of Hematology-Oncology, Schneider Children's Medical Center of Israel, Petach Tikva, Israel; Sackler Faculty of Medicine, Aviv University, Aviv.

Hannah Tamary (H)

Department of Hematology-Oncology, Schneider Children's Medical Center of Israel, Petach Tikva, Israel; Sackler Faculty of Medicine, Aviv University, Aviv, Israel; Pediatric Hematology Laboratory, Felsenstein Medical Research Center, Petach Tikva. htamary@tauex.tau.ac.il.

Orna Steinberg-Shemer (O)

Department of Hematology-Oncology, Schneider Children's Medical Center of Israel, Petach Tikva, Israel; Sackler Faculty of Medicine, Aviv University, Aviv, Israel; Pediatric Hematology Laboratory, Felsenstein Medical Research Center, Petach Tikva.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH